# OnCo record mfds (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/mfds/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "mfds" ;
  schema:name "Ministry of Food and Drug Safety (MFDS)"@en ;
  schema:alternateName "MFDS"@en, "식품의약품안전처"@en, "식약처"@en, "Korea Food and Drug Administration"@en, "KFDA"@en ;
  schema:description "South Korea's medicines regulator, which approves cancer drugs and clinical trials. It approved 783 drug trials in 2025, 304 of them for cancer medicines."@en ;
  schema:url <https://onco.cc/institutions/mfds/>, <https://www.mfds.go.kr> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.mfds.go.kr>, <https://www.mfds.go.kr/brd/m_99/view.do?seq=49738>, <https://www.mfds.go.kr/brd/m_99/view.do?seq=48944>, <https://www.mfds.go.kr/brd/m_99/view.do?seq=47414>, <https://www.dailypharm.com/user/news/8680> ;
  schema:addressCountry "KR" ;
  schema:addressLocality "Cheongju (Osong)" ;
  schema:latitude "36.639"^^xsd:decimal ;
  schema:longitude "127.331"^^xsd:decimal ;
  onco:related <https://onco.cc/institutions/pmda/> ;
  onco:drugs <https://onco.cc/drugs/lazertinib/> ;
  onco:companies <https://onco.cc/companies/yuhan/> ;
  onco:institutions <https://onco.cc/institutions/hira/>, <https://onco.cc/institutions/nhis-korea/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-lee-anticancer-drug-lag-korea-inquiry-2025/> .